血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病

2018-05-06 英国血液病学学会 Br J Haematol. 2018 May 6.

羟基尿素羟基脲镰状细胞疾病

2018年5月，英国血液病学学会(BSH)发布了应用羟基尿素治疗儿童和成人镰状细胞疾病指南，羟基尿素也称为羟基脲是英国目前唯一准许用于预防镰状细胞疾病复发性疼痛的药物。本文主要概述了羟基脲特殊适应证的最新证据并为临床医生应用概要提供指导。

中文标题：

2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病

英文标题：

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.

发布机构：

英国血液病学学会

发布日期：

2018-05-06

简要介绍：

2018年5月，英国血液病学学会(BSH)发布了应用羟基尿素治疗儿童和成人镰状细胞疾病指南，羟基尿素也称为羟基脲是英国目前唯一准许用于预防镰状细胞疾病复发性疼痛的药物。本文主要概述了羟基脲特殊适应证的最新证据并为临床医生应用概要提供指导。

拓展指南：与羟基尿相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病)] GetToolGuiderByIdResponse(projectId=1, id=1ce6b1c001589558, title=2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病, enTitle=Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline., guiderFrom=Br J Haematol. 2018 May 6., authorId=null, author=, summary=2018年5月，英国血液病学学会(BSH)发布了应用羟基尿素治疗儿童和成人镰状细胞疾病指南，羟基尿素也称为羟基脲是英国目前唯一准许用于预防镰状细胞疾病复发性疼痛的药物。本文主要概述了羟基脲特殊适应证的最新证据并为临床医生应用概要提供指导。 , cover=, journalId=null, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Sun May 06 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>2018年5月，英国血液病学学会(BSH)发布了应用羟基尿素治疗儿童和成人镰状细胞疾病指南，羟基尿素也称为羟基脲是英国目前唯一准许用于预防镰状细胞疾病复发性疼痛的药物。本文主要概述了羟基脲特殊适应证的最新证据并为临床医生应用概要提供指导。</div> <div><br> </div> <div> 拓展指南：<strong>与<font color=red>羟基尿</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=1ce6b1c001589558" title="2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病" target=_blank>2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E7%BE%9F%E5%9F%BA%E5%B0%BF" target=_blank>有关羟基尿更多指南</a></ul> </div>, tagList=[TagDto(tagId=31084, tagName=羟基尿素), TagDto(tagId=30630, tagName=羟基脲), TagDto(tagId=74611, tagName=镰状细胞疾病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3996, appHits=45, showAppHits=0, pcHits=2862, showPcHits=1465, likes=102, shares=0, comments=2, approvalStatus=1, publishedTime=Wed May 09 21:48:54 CST 2018, publishedTimeString=2018-05-06, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed May 09 21:48:54 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 13:08:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病)])
2018 BSH指南：应用羟基尿素治疗儿童和成人镰状细胞疾病
下载请点击：
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=314527, encodeId=63ed31452e2f, content=学习一下谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sat May 12 22:14:54 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314497, encodeId=313731449e01, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 12 19:25:29 CST 2018, time=2018-05-12, status=1, ipAttribution=)]
    2018-05-12 changjiu

    学习一下谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=314527, encodeId=63ed31452e2f, content=学习一下谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Sat May 12 22:14:54 CST 2018, time=2018-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314497, encodeId=313731449e01, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Sat May 12 19:25:29 CST 2018, time=2018-05-12, status=1, ipAttribution=)]
    2018-05-12 131****1460

    学习了受益匪浅

    0